Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Aug 11, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
- Jul 29, 2026Reported purchase · Form 4Snehal Patel, CEO and CFO · $9.2KOpen the filing ↗
- Jul 28, 2026Reported purchase · Form 4Snehal Patel, CEO and CFO · $20.4KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record2567 flagged findings
Reported transactions (Form 4)48since Feb 15, 2024
Corporate events (8-K)8since Sep 28, 2020
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-06-04share offering or dilution eventrecentOpen filing ↗“…OF STOCKHOLDERS’ EQUITY FOR THE THREE MONTHS ENDED MARCH 31, 2026 AND 2025 (UNAUDITED) Additional Total Common Stock Paid-in…”
+1 more passage from the same document
- “…stock via ATM program, net of costs 39,918 40 492,383 — 492,423 Net loss — — — ( 2,744,780 ) ( 2,744,780 ) Balances, March 31, 2025…”
- 2026-06-01share offering or dilution eventrecentOpen filing ↗“…expenses for the Phase III clinical trial. Investing Activities We did not use or generate cash from investing activities during…”
+1 more passage from the same document
- “…provided by financing activities was $11,999,484 during the year ended December 31, 2025, attributable to the sale of common stock…”
- 2026-06-01listing compliance noticerecentOpen filing ↗“…and costly, particularly after we are no longer an “emerging growth company.” Our management and other personnel will…”
- 2026-06-01capital return (buybacks/dividends)recentOpen filing ↗“…during the vesting period due to rounding up of fractional shares, had vested at approximately $ 2,009,657 value and 15,181 shares…”
+1 more passage from the same document
- “…and unrecognized at approximately $ 34,157 value. In 2025 and 2024, no shares of common stock grant vested. On January 23,…”
- 2026-06-01Department of Justice inquiryrecentOpen filing ↗“…to permit the import or export of products, or require us to initiate a product recall. The occurrence of any event or penalty…”
+1 more passage from the same document
- “…expedite the development or approval process. Other Healthcare Laws and Compliance Requirements Our sales, promotion, medical…”
- 2026-06-01reverse splitrecentOpen filing ↗“…of $ 2,065,366 and net proceeds of $ 1,869,111 , after deducting underwriting discounts and commissions and offering expenses borne…”
+1 more passage from the same document
- “…proceeds of $ 2,065,366 and net proceeds of $ 1,869,111 , after deducting underwriting discounts and commissions and offering…”
- 2025-11-14share offering or dilution eventrecentOpen filing ↗“…Sale of common stock via ATM program, net of costs 280,292 280 2,607,965 — 2,608,245 Net loss ( 4,025,278 ) ( 4,025,278 )…”
+1 more passage from the same document
- “…used in operating activities: Amortization 1,779 2,709 Stock-based compensation 4,632,642 1,783,566 Changes in operating assets and…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 256)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Aug 11, 2610-Q ↗Quarterly report
- Jun 4, 2610-Q ↗Quarterly report
- Jun 1, 2610-K ↗Annual report
- Mar 31, 26NT 10-K ↗Late filing notice
- Dec 18, 258-K ↗Current report · Shareholder vote results
- Nov 14, 2510-Q ↗Quarterly report
- Nov 3, 25DEFA14A ↗Shareholder meeting and votes
- Nov 3, 25DEF 14A ↗Shareholder meeting and votes
- Aug 14, 2510-Q ↗Quarterly report
- Jul 24, 258-K ↗Current report · Auditor change filing (8-K Item 4.01)
- May 20, 2510-Q ↗Quarterly report
- May 15, 25NT 10-Q ↗Late filing notice
- Apr 29, 25Form 4 ↗Insider transaction
256 filings on record, the oldest from Feb 20, 20.
Listing the 25 most recent filings of the 256 on record.
53
- Jul 24, 25Auditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
- Jun 17, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Feb 20, 24Auditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
- Jul 12, 22Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Dec 22, 20Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Oct 1, 20A senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
- Sep 28, 20Entered a material agreement+2 more in the same filing8-K 1.01 ↗
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
- Jul 29, 26Buy$9KSnehal PatelCEO and CFO↗
- Jul 28, 26Buy$20KSnehal PatelCEO and CFO↗
- Jul 27, 26Buy$20KSnehal PatelCEO and CFO↗
- Jul 24, 26Buy$14KSnehal PatelCEO and CFO↗
- Jul 23, 26Buy$33KSnehal PatelCEO and CFO↗
- Jan 13, 26Buy$54KSnehal PatelCEO and CFO↗
- Jan 12, 26Buy$80KSnehal PatelCEO and CFO↗
- Dec 31, 25Buy$92KSnehal PatelCEO and CFO↗
- Dec 30, 25Buy$63KSnehal PatelCEO and CFO↗
- Dec 18, 25Buy$52KSnehal PatelCEO and CFO↗
- Nov 25, 25Buy$39KSnehal PatelCEO and CFO↗
- Nov 7, 25Buy$89KSnehal PatelCEO and CFO↗
There are 28 more transactions in this stretch.
The full record holds 72 transactions and goes back to Dec 29, 22.
Its sector and its market
Greenwich LifeSciences Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Greenwich LifeSciences Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Greenwich LifeSciences Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 256 documents on file, from Feb 20, 2020 to Aug 11, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.